MedPath

This is a study to see the nature of antioxidants in saliva in patients with precancerous lesions like leukoplakia, oral submucous fibrosis and oral lichen planus.

Not Applicable
Conditions
Health Condition 1: L989- Disorder of the skin and subcutaneous tissue, unspecifiedHealth Condition 2: L438- Other lichen planusHealth Condition 3: L449- Papulosquamous disorder, unspecified
Registration Number
CTRI/2021/08/035541
Lead Sponsor
Dr Prasanti Murapala
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients diagnosed with oral leukoplakia

2.Patients with oral submucous fibrosis

3.Patients with oral lichen planus

Exclusion Criteria

1.Patients with more than one premalignant lesions

2.Patients suspecting/diagnosed with malignancy

3.Mentally retarded patients

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
patients with oral leukoplakia , oral submucous fibrosis and oral lichen planus will have lower levels of total antioxidant capacity in saliva when compared with healthy subjectsTimepoint: base line, Day 0
Secondary Outcome Measures
NameTimeMethod
patients with oral leukoplakia , oral submucous fibrosis and oral lichen planus will have higher levels of total antioxidant capacity in saliva when compared with healthy subjectsTimepoint: day 0
© Copyright 2025. All Rights Reserved by MedPath